Vivitrol

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

23 Suppliers, 9 USDMF, 7 CEP/COS, 2 EU WC, 6 KDMF, 32 NDC API, 17 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports

INTERMEDIATES

2 Suppliers

2 Suppliers

DOSSIERs // Finished Dosage Forms

45 Dossiers, 23 FDA Orange Book, 12 Europe, 4 Canada, 2 South Africa, 4 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 35 Kerry, 18 Corel Pharma Chem, 17 BASF, 12 Seppic, 11 Sigachi Industries, 11 Microlex e.U, 10 Roquette, 10 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 8 Actylis, 8 Gangwal Healthcare, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 DFE Pharma, 6 Lonza Capsugel, 4 Kima Chemical, 4 Nanjing Well Pharmaceutical, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 4 ACG Worldwide, 3 DKSH, 3 The Dow Chemical Company, 3 Prachin Chemical, 3 Vasa Pharmachem, 2 Nomisma Healthcare, 2 Seqens, 2 Jai Radhe Sales, 2 Evonik, 2 Qualicaps, 1 Ingredion Pharma Solutions, 1 Nanjing Bold Chemical, 1 Pfanstiehl, 1 Pharmatrans-Sanaq, 1 Vertellus, 1 SPI Pharma, 1 Aeon Procare, 1 Finar, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Alcedo Pharmachem, 1 Clariant

EXCIPIENTS BY APPLICATIONS

60 Coating Systems & Additives, 49 Fillers, Diluents & Binders, 42 Controlled & Modified Release, 22 Direct Compression, 19 Thickeners and Stabilizers, 19 Solubilizers, 18 Granulation, 17 Disintegrants & Superdisintegrants, 14 Lubricants & Glidants, 13 Parenteral, 13 Topical, 11 Film Formers & Plasticizers, 11 Co-Processed Excipients, 11 Taste Masking, 9 Empty Capsules, 6 Emulsifying Agents, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Chewable & Orodispersible Aids, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 15 Finished Drug Prices

MARKET PLACE

14 APIs, 3 DOSSIERS // FDF

PATENTS

86 US Patents

86 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 7 Others

DIGITAL CONTENT

47 News

47 News

List of manufacturers, suppliers & exporters who supply chemical intermediates & fine chemicals related to Vivitrol

Vivitrol

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

23 Suppliers

9 USDMF

7 CEP/COS

2 EU WC

6 KDMF

32 NDC API

17 Listed Suppliers

DEVELOPMENTS

14 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

INTERMEDIATES

2 Suppliers

DOSSIERs // Finished Dosage Forms

45 Dossiers

23 FDA Orange Book

12 Europe

4 Canada

2 South Africa

4 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

35 Kerry

18 Corel Pharma Chem

17 BASF

12 Seppic

11 Sigachi Industries

11 Microlex e.U

10 Roquette

10 Gangwal Chemicals

9 Ideal Cures Pvt Ltd

8 Actylis

8 Gangwal Healthcare

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 DFE Pharma

6 Lonza Capsugel

4 Kima Chemical

4 Nanjing Well Pharmaceutical

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

4 ACG Worldwide

3 DKSH

3 The Dow Chemical Company

3 Prachin Chemical

3 Vasa Pharmachem

2 Nomisma Healthcare

2 Seqens

2 Jai Radhe Sales

2 Evonik

2 Qualicaps

1 Ingredion Pharma Solutions

1 Nanjing Bold Chemical

1 Pfanstiehl

1 Pharmatrans-Sanaq

1 Vertellus

1 SPI Pharma

1 Aeon Procare

1 Finar

1 Qianhao Chemical (Hebei) Co., Ltd

1 Alcedo Pharmachem

1 Clariant

EXCIPIENTS BY APPLICATIONS

60 Coating Systems & Additives

49 Fillers, Diluents & Binders

42 Controlled & Modified Release

22 Direct Compression

CAPSULE, EXTENDED RELEASE;ORAL - 100MG;4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 20MG;0.8MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 30MG;1.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 50MG;2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 60MG;2.4MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 80MG;3.2MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

Integrated solutions for all your projects.
M2i Group provides integrated solutions for all your p...